United BioPharma (UBP) is a clinical stage biopharmaceutical company, founded in 2013 as a spin-off from UBIAsia, its parent company.
UBP is dedicated to research, development and manufacturing of novel
monoclonal antibodies (mAbs) for infectious diseases, cancer and immune disorders. With UBP’s Headquarters in Taiwan, subsidiary companies in Shanghai and Yangzhou China, and liaison offices in the US, we are a global team who are highly passionate about developing first-in-class, best-in-class therapeutic mAbs and delivering high-quality, affordable medicines to bring better life to the patients.
We are an entrepreneurial biopharmaceutical company delivering life-changing solutions to improve global health.
We dedicate our scientific rigor to maintaining an innovation-driven, patient-oriented culture with outstanding execution and continuous improvement.
Our foundation is our people. Every one shares in our vision and purpose. We transcend geographical boundaries to meet the ever-changing challenges of disease treatment. We believe that leadership is based on the courage to take risks, a sense of urgency, respect for people and the assurance that our integrity is never compromised.